(Q2)Jul 28, 2024 | (Q1)Apr 28, 2024 | (FY)Jan 28, 2024 | (Q4)Jan 28, 2024 | (Q3)Oct 29, 2023 | (Q2)Jul 30, 2023 | (Q1)Apr 30, 2023 | (FY)Jan 29, 2023 | (Q4)Jan 29, 2023 | (Q3)Oct 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 128.23%14.49B | 427.14%15.35B | 397.96%28.09B | 411.52%11.5B | 1,770.41%7.33B | 399.84%6.35B | 68.17%2.91B | -38.07%5.64B | -25.88%2.25B | -74.19%392M |
Net income from continuing operations | 168.20%16.6B | 628.39%14.88B | 581.32%29.76B | 768.81%12.29B | 1,259.26%9.24B | 843.45%6.19B | 26.27%2.04B | -55.21%4.37B | -52.91%1.41B | -72.40%680M |
Operating gains losses | -230.51%-195M | -592.86%-69M | -628.89%-238M | -2,720.00%-262M | 527.27%69M | -942.86%-59M | -17.65%14M | 145.00%45M | -80.77%10M | 157.89%11M |
Depreciation and amortization | 18.63%433M | 6.77%410M | -2.33%1.51B | -9.15%387M | -8.37%372M | -3.44%365M | 14.97%384M | 31.52%1.54B | 37.86%426M | 36.24%406M |
Remuneration paid in stock | 37.10%1.15B | 37.55%1.01B | 31.01%3.55B | 34.69%994M | 31.41%979M | 29.78%841M | 27.16%735M | 35.18%2.71B | 33.94%738M | 33.27%745M |
Deferred tax | -127.75%-1.7B | -38.94%-1.58B | -15.02%-2.49B | 87.94%-78M | 0.38%-530M | -68.40%-746M | -109.41%-1.14B | -433.00%-2.16B | -188.84%-647M | -2,433.33%-532M |
Other non cashItems | -110.29%-143M | -326.47%-145M | -120.65%-278M | -640.00%-108M | -51.11%-68M | -1,260.00%-68M | -102.47%-34M | 2,763.83%1.35B | -9.09%20M | -600.00%-45M |
Change In working capital | -854.02%-1.66B | -7.74%834M | -68.65%-3.72B | -698.95%-1.72B | -213.06%-2.73B | -700.00%-174M | 154.79%904M | 34.37%-2.21B | 142.21%287M | 50.71%-873M |
-Change in receivables | 40.84%-1.77B | -838.89%-2.37B | -850.85%-6.17B | -256.48%-1.69B | -403.17%-1.24B | -2,589.17%-2.99B | 68.02%-252M | 137.11%822M | 256.07%1.08B | 212.02%410M |
-Change in inventory | -372.20%-803M | -201.94%-577M | 96.16%-98M | 28.75%-503M | 19.01%-456M | 140.69%295M | 201.07%566M | -229.97%-2.55B | -88.77%-706M | -377.12%-563M |
-Change in prepaid assets | 289.39%714M | -237.67%-726M | -0.33%-1.52B | -464.29%-1.19B | 3.24%255M | -28.67%-377M | 82.95%-215M | 11.55%-1.52B | -32.91%-210M | 115.68%247M |
-Change in payables and accrued expense | -102.35%-65M | 497.14%4.18B | 350.13%3.56B | 5,111.11%1.35B | -24.98%-1.26B | 194.98%2.76B | -21.26%700M | -31.24%790M | -104.46%-27M | -858.65%-1.01B |
-Change in other current liabilities | 99.24%261M | 207.62%323M | 103.97%514M | 104.00%306M | -166.67%-28M | 1,410.00%131M | 50.00%105M | 31.25%252M | 345.90%150M | -72.90%42M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 128.23%14.49B | 427.14%15.35B | 397.96%28.09B | 411.52%11.5B | 1,770.41%7.33B | 399.84%6.35B | 68.17%2.91B | -38.07%5.64B | -25.88%2.25B | -74.19%392M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -613.90%-3.18B | -576.93%-5.69B | -243.27%-10.57B | -203,533.33%-6.11B | -200.70%-3.17B | -127.56%-446M | -132.20%-841M | 175.03%7.38B | 99.81%-3M | 170.92%3.15B |
Net PPE purchase and sale | -238.06%-977M | -48.79%-369M | 41.68%-1.07B | 50.10%-254M | 47.55%-278M | 33.26%-289M | 31.30%-248M | -87.81%-1.83B | -86.45%-509M | -138.74%-530M |
Net business purchase and sale | -143.40%-572M | 42.76%-174M | -69.39%-83M | --0 | --456M | -1,707.69%-235M | -744.44%-304M | 81.37%-49M | --0 | --0 |
Net investment purchase and sale | -2,968.42%-1.64B | -1,682.01%-5.15B | -201.70%-9.41B | -1,257.11%-5.86B | -190.46%-3.33B | -97.24%57M | -109.60%-289M | 207.75%9.26B | 140.38%506M | 191.63%3.68B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -613.90%-3.18B | -576.93%-5.69B | -243.27%-10.57B | -203,533.33%-6.11B | -200.70%-3.17B | -127.56%-446M | -132.20%-841M | 175.03%7.38B | 99.81%-3M | 170.92%3.15B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -102.39%-10.32B | -2,359.21%-9.35B | -17.35%-13.63B | -119.14%-3.63B | -20.57%-4.53B | -35.54%-5.1B | 84.46%-380M | -722.90%-11.62B | -122.28%-1.66B | -164.30%-3.75B |
Net issuance payments of debt | ---- | ---- | ---1.25B | --0 | --0 | ---- | ---- | --0 | --0 | --0 |
Net common stock issuance | -133.39%-7.16B | ---7.74B | 5.04%-9.53B | -119.21%-2.66B | -9.24%-3.81B | 8.31%-3.07B | --0 | ---10.04B | ---1.21B | ---3.49B |
Cash dividends paid | -146.00%-246M | 1.01%-98M | 0.75%-395M | -1.02%-99M | 3.00%-97M | 0.00%-100M | 1.00%-99M | 0.25%-398M | 2.97%-98M | 0.00%-100M |
Proceeds from stock option exercised by employees | --0 | 15.85%285M | 13.52%403M | --0 | 8.33%156M | 0.00%1M | 20.59%246M | 26.33%355M | 50.00%6M | -3.36%144M |
Net other financing activities | -143.92%-1.67B | -240.04%-1.79B | -86.19%-2.86B | -148.15%-871M | -149.04%-777M | -114.78%-683M | 4.87%-527M | 23.02%-1.54B | 45.83%-351M | 32.32%-312M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -102.39%-10.32B | -2,359.21%-9.35B | -17.35%-13.63B | -119.14%-3.63B | -20.57%-4.53B | -35.54%-5.1B | 84.46%-380M | -722.90%-11.62B | -122.28%-1.66B | -164.30%-3.75B |
Net cash flow | ||||||||||
Beginning cash position | 49.38%7.59B | 114.81%7.28B | 70.30%3.39B | 97.11%5.52B | 95.22%5.88B | 30.67%5.08B | 70.30%3.39B | 134.95%1.99B | 117.39%2.8B | -46.46%3.01B |
Current changes in cash | 22.54%984M | -81.83%307M | 178.13%3.89B | 198.98%1.76B | -70.42%-363M | 191.88%803M | -10.91%1.69B | 22.40%1.4B | -16.10%589M | 95.09%-213M |
End cash Position | 45.72%8.57B | 49.38%7.59B | 114.81%7.28B | 114.81%7.28B | 97.11%5.52B | 95.22%5.88B | 30.67%5.08B | 70.30%3.39B | 70.30%3.39B | 117.39%2.8B |
Free cash from | 122.99%13.51B | 462.37%14.98B | 609.59%27.02B | 546.64%11.25B | 5,211.59%7.05B | 623.89%6.06B | 94.38%2.66B | -53.17%3.81B | -36.99%1.74B | -110.64%-138M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.